India Life Sciences Fund invests in Sharp Sight, Murli Krishna Pharma

India Life Sciences Fund invests in Sharp Sight, Murli Krishna Pharma

Photo: Pixabay

Swaraj Singh Dhanjal

16 June, 2020

India Life Sciences fund III Murli Krishna Pharma Pvt. Ltd Sharp Sight

Printed by Unregistered user on Thu, 25 Dec 2025 11:33:59 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

India: PE firm InvAsent invests $9.2m in eye care chain Sharp Sight

Read more from India

Bharti Enterprises, Warburg Pincus jointly invest in Haier India

Blue Tokai-backer Anicut Capital closes third credit fund at $142m